1
/
of
0
FDA Drug Approval, N022032, OMEPRAZOLE
FDA Drug Approval, N022032, OMEPRAZOLE
Regular price
$149.00 USD
Regular price
Sale price
$149.00 USD
Unit price
/
per
NDA: 022032
Company: DEXCEL PHARMA
Drug Name: OMEPRAZOLE
Active Ingredients: OMEPRAZOLE
Strength: 20MG
Dosage Form/Route: TABLET, DELAYED RELEASE;ORAL
Action Date: 12/04/2007
Marketing Status: Over-the-counter
Submission Classification: Type 5 - New Formulation or New Manufacturer
Company: DEXCEL PHARMA
Drug Name: OMEPRAZOLE
Active Ingredients: OMEPRAZOLE
Strength: 20MG
Dosage Form/Route: TABLET, DELAYED RELEASE;ORAL
Action Date: 12/04/2007
Marketing Status: Over-the-counter
Submission Classification: Type 5 - New Formulation or New Manufacturer
Couldn't load pickup availability
- Status: Pending Fast-Track Request
- Delivery: Approximately 1 to 2 weeks
NOTE: This document is not currently in our library. Upon purchase, we will request the document from the FDA FOIA office. Learn more about Fast-Track Requests here.
View full details